The turmoil surrounding the CBD question has obscured other important debates, such as how to alter DHSEA is such a way that more scientific information can be conveyed to consumers.
An expert panel has recommended an expanded treatment envelope for the EPA drug Vascepa. An expert says the move won’t affect the supplement market directly but does add to recent official recognition of the health benefits of omega-3s.
Although a source of delight in many children, flatulence is often frowned upon in adulthood. One product takes direct aim at the problem and its accompanying odor.
The Journal of Dietary Supplements is planning a special issue devoted to the toxicology, pharmacology, and potential regulatory pathways for CBD and other cannabinoids, and is inviting submissions.
The newly announced USP verification of two MeriCal probiotics products—a first in the industry—represents years of work behind the scenes, an executive said.
An antioxidant, astaxanthin has been linked to healthier skin, heart health, joint pain, and now, research suggests it may also reduce depression and stress in healthy subjects as well as improve memory in subjects with mild cognitive decline.
Introducing user fees for the food industry – of which dietary supplements are a subset – is a tough proposition, says Dan Fabricant, president and CEO of the Natural Products Association.
Germany’s federal government now confirms that cannabidiol (CBD) is to be classified as novel food citing an absence of evidence of its consumption before 15 May 1997.
